Smith & Nephew Iodosorb Ointment 10g x 1 (Cadoxemer Iodine 0.9 %)

Iodosorb Cadoxemer Iodine 0.9 % ointment

Iodosorb Cadoxemer Iodine Ointment reduces bacteria, absorbs exudate, pus and debris, facilitates desloughing and maintains a moist wound environment to promote healing of chronic ulcers and wounds such as venous stasis ulcers, pressure sores, diabetic foot ulcers, and infected traumatic and surgical wounds.

Each gram of cadexomer iodine can absorb up to 6ml of fluid. When Iodosorb Cadoxemer Iodine Ointment needs changing, it changes colour for easy identification. The ointment is non-adhesive so can be easily removed without damaging the fragile tissue underneath.

Directions

• Thoroughly clean the wound and surrounding area with a gentle stream of sterile water or saline. Remove excess fluid, leaving wound surface slightly moist.
• Apply Iodosorb Ointment directly to a dry, sterile non-adherent gauze, ensuring sufficient ointment to cover all parts of the wound.
• Position prepared dressing onto the wound.
• Lightly smooth a gloved finger over the dressing to spread the ointment underneath to the shape of the wound and to a depth of 3mm.
• Cover with an appropriate secondary dressing e.g. Melolin or Allevyn. Apply compression bandaging where appropriate.
• Discard remaining contents of tube after application.

Ingredients

Contains 50% w/w cadexomer Iodine equivalent to 0.9% w/w available Iodine.

Cautions

• As Iodosorb Ointment contains 0.9% w/w Iodine it should not be used in patients with known or suspected Iodine sensitivity.
• Iodosorb Ointment is contraindicated in Hashimoto's thyroiditis and in cases of nodular goitre.- Iodosorb Ointment should not be used in children under 12 years of age.
• Iodine may be absorbed systemically, especially when large wounds are treated.
• Patients with severely impaired renal function or a past history of thyroid disorder are more susceptible to alterations in thyroid metabolism with chronic Iodosorb Ointment therapy.
• In endemic goitre, there have been isolated reports of hyperthyroidism associated with exogenous iodine.
• Iodine crosses the placental barrier. Clinical experience of use in pregnant women is limited.
• Iodosorb medicated ointment should therefore not be used in pregnant women.
• Iodine is secreted into breast milk. Clinical experience of use in lactating women is limited.
• Iodosorb medicated ointment should therefore not be used in lactating women.
• There is a potential risk of interaction with lithium resulting in an increased possibility of hyperthyroidism. Iodosorb Ointment should not be used with mercurial antiseptics e.g. mercurochrome, thiomersal.
• A single application should not exceed 50g. The total amount of Iodosorb used in one week should not exceed 150g.
• The duration of treatment should not exceed 3 months in any single course of treatment.
• There is no experience in children, therefore Iodosorb Ointment is notrecommended